The bioprocess containers market is in rapid expansion driven by strong adoption of single-use technologies across biopharma manufacturing, rising biologics production and need for contamination-reducing, scalable solutions. Market estimates place the global market at roughly USD 3.1–3.9 billion in the mid-2020s with projections to exceed ~USD 30+ billion by the early-to-mid 2030s, implying high double-digit CAGR through the decade. North America led the market in 2024 while Asia-Pacific is expected to be the fastest growing region. Key product trends are 2D (hanging) bags dominating today and 3D (tank liners, mixing/production) containers showing the fastest growth.
Download the free sample and get the full report for complete insights and forecasts on this market @ https://www.towardshealthcare.com/download-sample/5565
Top Leading Companies — strengths and products
Sartorius Stedim Biotech (Sartorius) — Germany / global
◉Strengths: Market leader in single-use bag technology, strong R&D and large automated manufacturing footprint for both 2D and 3D bags; strong quality/validation services for biopharma customers.
◉Key products: Flexsafe® and Flexboy® family (2D & 3D single-use bags for storage, transfer and shipping; volumes from mL to multi-1000 L), dedicated liquid storage & shipping systems, custom bag assemblies.
◉Why it matters: Broad bag portfolio, vertical integration and recent capacity expansion to meet scale-up demand.
Thermo Fisher Scientific (Thermo Scientific / Fisher Scientific) — USA / global
◉Strengths: Very large life-sciences distribution and manufacturing footprint; wide portfolio that pairs containers with tubing, connectors, bottles and supporting consumables; strong technical support and global supply chain.
◉Key products: Standard single-use BioProcess Containers (BPCs), tubing assemblies, Nalgene bottles/carboys, enhanced single-use fermentor and storage bags; configurable assemblies for media, buffer and product handling.
◉Why it matters: Offers off-the-shelf and configurable containment solutions that integrate with large laboratory and production workflows.
Merck KGaA — operating under MilliporeSigma in US/Canada — Germany / global
◉Strengths: Deep downstream/upstream single-use platform expertise, strong regulatory/compliance support and engineered single-use systems for complex applications (e.g., ADCs).
◉Key products: Mobius® single-use manufacturing family (mixing systems, reactors, single-use assemblies), Mobius® ADC reactor (single-use reactor designed for ADC manufacture), sterile sampling assemblies (NovaSeptum®) and other single-use consumables.
◉Why it matters: Focus on higher-value single-use platforms and integrated process solutions for advanced biologics.
Danaher Corporation (including Pall and Cytiva brands) — USA / global
◉Strengths: Large life-science conglomerate with complementary portfolios after consolidation (filtration, single-use bags, bioreactors, consumables); strong global sales/service and M&A-driven tech breadth.
◉Key products: Pall single-use assemblies and filtration solutions; Cytiva (formerly GE Life Sciences) single-use bioreactor bags, ReadyToProcess™ Cellbag / rocking bioreactor consumables and a range of single-use process consumables and accessories.
◉Why it matters: Combines filtration + single-use containment + hardware for end-to-end bioprocessing at scale.
Corning Life Sciences — USA / global
◉Strengths: Strong materials science and film expertise, high quality single-use film production and a wide set of off-the-shelf and custom bag formats; known for robust testing and biocompatible films.
◉Key products: Single-use bioprocess bags (collection bags, cell expansion bags, tank liners), film-based containment and accessory manifolds for closed-system transfers; CellSTACK/HYPERStack adjacent portfolio for scale-up.
◉Why it matters: Corning’s film and container expertise supports low extractables and reliable single-use containment for sensitive processes.
Avantor (VWR / Avantor Fluid Handling) — USA / global
◉Strengths: Broad distribution plus in-house single-use manufacturing (expanded via acquisitions) and custom bag assembly capability; strong customer reach to labs and CMOs.
◉Key products: FlexFilm and other single-use bioprocess bags (2D & 3D), tank liners, media/mixing bags, rocker bags compatible with industry hardware, sterile assemblies and custom configured fluid-handling solutions.
◉Why it matters: Combines supply chain reach with manufacturing for quick availability of standard and custom bioprocess containers.
Saint-Gobain Life Sciences — France / global
◉Strengths: Multilayer film manufacturing expertise and global production footprint for large-volume single-use bags (range of materials and barrier properties); emphasis on consistent film formulations and cGMP manufacturing.
◉Key products: Single-use bioprocess bags (50 mL up to 3,000 L), cell therapy bags, overmolding and closure systems, custom containment assemblies and PUPSIT assemblies.
◉Why it matters: Saint-Gobain supplies film and finished bags used widely by OEMs and end users who need traceable materials and strong barrier/performance characteristics.
Immediate Delivery Available | Buy This Premium Research @ http://towardshealthcare.com/price/5565
Access our exclusive, data-rich dashboard dedicated to the laboratory equipment sector – built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway.
Access the Dashboard: https://www.towardshealthcare.com/access-dashboard
Become a valued research partner with us – https://www.towardshealthcare.com/schedule-meeting
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About the Author
